Application Nr Approved Date Route Status External Links
ANDA075028 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Pentoxifylline Extended-Release Tablet Is Indicated For The Treatment Of Patients With Intermittent Claudication On The Basis Of Chronic Occlusive Arterial Disease Of The Limbs. Pentoxifylline Extended-Release Tablet Can Improve Function And Symptoms But Is Not Intended To Replace More Definitive Therapy, Such As Surgical Bypass, Or Removal Of Arterial Obstructions When Treating Peripheral Vascular Disease.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pentoxifylline PENTOXIFYLLINE ZINC1530776

Comments